ArticleEndoscopic ultrasound
The role of artificial intelligence and deep learning in determining the histopathological grade of pancreatic neuroendocrine tumors by using EUS images.
Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Diagnostic performance of artificial intelligence versus conventional imaging for differentiating G2/G3 from G1 pancreatic neuroendocrine tumors: a systematic review and meta-analysis.BMC medical imaging · 2026Pooled it
- Artificial Intelligence in Pancreatic Endoscopic Ultrasonography: From Image-Based Diagnosis to Cytopathology.Journal of clinical medicine · 2026Review
- Multi-omics profiling of pancreatic neuroendocrine tumors: Interplay of genomic instability and the tumor microenvironment (Review).Oncology letters · 2026Review
- Review
- ARTEMIS: a pilot study comparing AI-based and expert therapeutic decisions in simulated clinical cases of neuroendocrine neoplasms.NPJ digital medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Pancreatic neuroendocrine tumors (pNETs) are relatively rare and consist of 2% of the all pancreatic tumors. Although some of pNETs have a benign, nonprogressive course, some may be progressive and result with metastasis. We aimed to estimate the grade of pNETs by using artificial intelligence (AI) via deep learning (DL) algorithms as indexing to cyto/histopathological classification according to the World Health Organization 2017. Methods: A total of 803 EUS images were collected from 44 patients who had a cyto/histo-pathologically confirmed diagnosis with EUS fine-needle aspiration or biopsy (FNA/B). First, raw EUS images were prepared for processing by AI via DL algorithms, and convolutional neural networks were utilized to train the machine to predict the grades from EUS images. IBM SPSS 25.0 program was used for statistical analyses. Results: Thirty of the 44 patients (68%) were female, with a median age of 61 (range, 16-80) years. pNETs were mostly located in the pancreatic head: 24 cases (55%). Location was the neck in 3 (7%), body in 10 (22%), and tail in 7 (16%) patients. According to EUS-FNA/B results, 27 patients were grade 1 (G1) (61%); 12, grade 2 (G2) (27%); and 5, grade 3 (G3) (12%). In reference to the performance of AI for predicting the pathological grade, sensitivity was 94.29%; specificity, 97.14%; and accuracy, 96.19%. When the patient groups were subanalyzed as G1, G2, and G3 by the AI model to predict the pathological grade, the accuracy was as follows: for G1, 93.15%; for G2, 91.61%; and for G3, 98.05%. Conclusions: This pilot study suggests that pNET grade prediction can be reliably done on EUS images using AI-based technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.